0001643918-23-000002.txt : 20230607
0001643918-23-000002.hdr.sgml : 20230607
20230606191729
ACCESSION NUMBER: 0001643918-23-000002
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20230607
DATE AS OF CHANGE: 20230606
EFFECTIVENESS DATE: 20230607
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Biodexa Pharmaceuticals Plc
CENTRAL INDEX KEY: 0001643918
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-483522
FILM NUMBER: 23997386
BUSINESS ADDRESS:
STREET 1: 1 CASPIAN POINT
STREET 2: CASPIAN WAY
CITY: CARDIFF
STATE: X0
ZIP: CF10 4DQ
BUSINESS PHONE: 44 (0)1235 888300
MAIL ADDRESS:
STREET 1: 1 CASPIAN POINT
STREET 2: CASPIAN WAY
CITY: CARDIFF
STATE: X0
ZIP: CF10 4DQ
FORMER COMPANY:
FORMER CONFORMED NAME: Midatech Pharma Plc
DATE OF NAME CHANGE: 20150602
D
1
primary_doc.xml
X0708
D
LIVE
0001643918
Biodexa Pharmaceuticals Plc
1 CASPIAN POINT
CASPIAN WAY
CARDIFF
X0
UNITED KINGDOM
CF10 4DQ
44 (0)2920480180
UNITED KINGDOM
Midatech Pharma Plc
Other
Public limited company organized under the laws of England and Wales.
true
Stephen
Stamp
c/o Biodexa Pharmaceuticals Plc
1 Caspian Point, Caspian Way
Cardiff
X0
UNITED KINGDOM
CF10 4DQ
Executive Officer
Director
Simon
Turton
c/o Biodexa Pharmaceuticals Plc
1 Caspian Point, Caspian Way
Cardiff
X0
UNITED KINGDOM
CF10 4DQ
Director
Stephen
Parker
c/o Biodexa Pharmaceuticals Plc
1 Caspian Point, Caspian Way
Cardiff
X0
UNITED KINGDOM
CF10 4DQ
Director
Sijmen
de Vries
c/o Biodexa Pharmaceuticals Plc
1 Caspian Point, Caspian Way
Cardiff
X0
UNITED KINGDOM
CF10 4DQ
Director
Dmitry
Zamoryakhin
c/o Biodexa Pharmaceuticals Plc
1 Caspian Point, Caspian Way
Cardiff
X0
UNITED KINGDOM
CF10 4DQ
Executive Officer
Pharmaceuticals
Decline to Disclose
- 06b
false
2023-05-23
false
true
true
false
0
Ladenburg Thalmann & Co. Inc.
505
None
None
640 5th Avenue
4th Floor
New York
NY
NEW YORK
10019
CA
CALIFORNIA
FL
FLORIDA
MN
MINNESOTA
NV
NEVADA
NJ
NEW JERSEY
NY
NEW YORK
true
3320388
3320388
0
false
15
265631
0
8% of aggregate gross proceeds
0
false
Biodexa Pharmaceuticals Plc
/s/ Stephen Stamp
Stephen Stamp
CEO and CFO
2023-06-06